(Q42725846)

English

XL647--a multitargeted tyrosine kinase inhibitor: results of a phase II study in subjects with non-small cell lung cancer who have progressed after responding to treatment with either gefitinib or erlotinib.

scientific article published on January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

XL647--a multitargeted tyrosine kinase inhibitor: results of a phase II study in subjects with non-small cell lung cancer who have progressed after responding to treatment with either gefitinib or erlotinib (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Nathan A Pennell

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

M Catherine Pietanza

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Thomas James Lynch

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Primo N Lara

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

John Cho

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Ronald H Yanagihara

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Nandagopal Vrindavanam

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Naveed Mahfooz Chowhan

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Shirish M Gadgeel

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Roel Funke

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Ben Mitchell

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Heather A Wakelee

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Vincent A Miller

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

1 January 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Journal of Thoracic Oncology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

219-226

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1141478

Identifiers

10.1097/JTO.0B013E31822EEBF9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22011666%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42725846&oldid=1646968431"